W. Craig, State???of???the???Art Clinical Article: Pharmacokinetic/Pharmacodynamic Parameters: Rationale for Antibacterial Dosing of Mice and Men, Clinical Infectious Diseases, vol.26, issue.1, pp.1-10, 1998.
DOI : 10.1086/516284

C. Joukhadar, M. Frossard, B. Mayer, M. Brunner, N. Klein et al., Impaired target site penetration of ?? -lactams may account for therapeutic failure in patients with septic shock, Critical Care Medicine, vol.29, issue.2, pp.385-391, 2001.
DOI : 10.1097/00003246-200102000-00030

M. Müller, A. De-la-pena, and H. Derendorf, Issues in Pharmacokinetics and Pharmacodynamics of Anti-Infective Agents: Distribution in Tissue, Antimicrobial Agents and Chemotherapy, vol.48, issue.5, pp.1441-1453, 2004.
DOI : 10.1128/AAC.48.5.1441-1453.2004

F. Tomaselli, A. Maier, V. Matzi, F. Smolle-juttner, and P. Dittrich, Penetration of Meropenem into Pneumonic Human Lung Tissue as Measured by In Vivo Microdialysis, Antimicrobial Agents and Chemotherapy, vol.48, issue.6, pp.2228-2232, 2004.
DOI : 10.1128/AAC.48.6.2228-2232.2004

C. Dahyot, S. Marchand, G. Pessini, C. Pariat, B. Debaene et al., Microdialysis Study of Imipenem Distribution in Skeletal Muscle and Lung Extracellular Fluids of Acinetobacter baumannii-Infected Rats, Antimicrobial Agents and Chemotherapy, vol.50, issue.6, pp.2265-2267, 2006.
DOI : 10.1128/AAC.00190-06

S. Marchand, C. Dahyot, I. Lamarche, O. Mimoz, and W. Couet, Microdialysis Study of Imipenem Distribution in Skeletal Muscle and Lung Extracellular Fluids of Noninfected Rats, Antimicrobial Agents and Chemotherapy, vol.49, issue.6, pp.2356-2361, 2005.
DOI : 10.1128/AAC.49.6.2356-2361.2005

O. Mimoz, R. D. Adoun, M. Marchand, S. Breilh, D. Brumpt et al., Steady-state trough serum and epithelial lining fluid concentrations of teicoplanin 12???mg/kg per day in patients with ventilator-associated pneumonia, Intensive Care Medicine, vol.45, issue.5, pp.775-779, 2006.
DOI : 10.1007/s00134-006-0136-3

D. Baldwin, D. Honeybourne, and R. Wise, Pulmonary disposition of antimicrobial agents: methodological considerations., Antimicrobial Agents and Chemotherapy, vol.36, issue.6, pp.1171-1175, 1992.
DOI : 10.1128/AAC.36.6.1171

J. Andrews, D. Honeybourne, G. Jevons, N. Brenwald, D. Cunningham et al., Concentrations of levofloxacin (HR 355) in the respiratory tract following a single oral dose in patients undergoing fibre-optic bronchoscopy, Journal of Antimicrobial Chemotherapy, vol.40, issue.4, pp.573-577, 1997.
DOI : 10.1093/jac/40.4.573

E. Boselli, D. Breilh, T. Rimmele, S. Djabarouti, J. Toutain et al., Pharmacokinetics and intrapulmonary concentrations of linezolid administered to critically ill patients with ventilator-associated pneumonia*, Critical Care Medicine, vol.33, issue.7, pp.1529-1533, 2005.
DOI : 10.1097/01.CCM.0000168206.59873.80

D. Honeybourne, C. Tobin, G. Jevons, J. Andrews, and R. Wise, Intrapulmonary penetration of linezolid, Journal of Antimicrobial Chemotherapy, vol.51, issue.6, pp.1431-1434, 2003.
DOI : 10.1093/jac/dkg262

E. Boselli, D. Breilh, T. Rimmele, J. Poupelin, M. Saux et al., Plasma and lung concentrations of ceftazidime administered in continuous infusion to critically ill patients with severe nosocomial pneumonia, Intensive Care Medicine, vol.30, issue.5, pp.989-991, 2004.
DOI : 10.1007/s00134-004-2171-2

E. Boselli, D. Breilh, M. Cannesson, F. Xuereb, T. Rimmele et al., Steady-state plasma and intrapulmonary concentrations of piperacillin/tazobactam 4???g/0.5???g administered to critically ill patients with severe nosocomial pneumonia, Intensive Care Medicine, vol.30, issue.5, pp.976-979, 2004.
DOI : 10.1007/s00134-004-2222-8

E. Boselli, D. Breilh, T. Rimmele, S. Djabarouti, M. Saux et al., Pharmacokinetics and intrapulmonary diffusion of levofloxacin in critically ill patients with severe community-acquired pneumonia, Critical Care Medicine, vol.33, issue.1, pp.104-109, 2005.
DOI : 10.1097/01.CCM.0000150265.42067.4C

E. Boselli, D. Breilh, M. Saux, J. Gordien, and B. Allaouchiche, Pharmacokinetics and lung concentrations of ertapenem in patients with ventilator-associated pneumonia, Intensive Care Medicine, vol.270, issue.12, pp.2059-2062, 2006.
DOI : 10.1007/s00134-006-0401-5

E. Boselli, D. Breilh, F. Duflo, M. Saux, R. Debon et al., Steady-state plasma and intrapulmonary concentrations of cefepime administered in continuous infusion in critically ill patients with severe nosocomial pneumonia*, Critical Care Medicine, vol.31, issue.8, pp.2102-2106, 2003.
DOI : 10.1097/01.CCM.0000069734.38738.C8

A. Carcas, J. Garcia-satue, P. Zapater, and J. Frias-iniesta, Tobramycin penetration into epithelial lining fluid of patients with pneumonia, Clinical Pharmacology & Therapeutics, vol.65, issue.3, pp.245-250, 1999.
DOI : 10.1016/S0009-9236(99)70103-7

M. Richer, S. Allard, L. Manseau, F. Vallee, R. Pak et al., Suction-induced blister fluid penetration of cefdinir in healthy volunteers following ascending oral doses, Antimicrobial Agents and Chemotherapy, vol.39, issue.5, pp.1082-1086, 1995.
DOI : 10.1128/AAC.39.5.1082